Hesham Basma

502 total citations
9 papers, 355 citations indexed

About

Hesham Basma is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hesham Basma has authored 9 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hesham Basma's work include Streptococcal Infections and Treatments (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Neonatal and Maternal Infections (3 papers). Hesham Basma is often cited by papers focused on Streptococcal Infections and Treatments (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Neonatal and Maternal Infections (3 papers). Hesham Basma collaborates with scholars based in United States, Germany and Canada. Hesham Basma's co-authors include Anna Norrby‐Teglund, Allison McGeer, Donald E. Low, Malak Kotb, Benjamin Schwartz, Y. Guédez, Jan Andersson, Malak Kotb, Pi-Wan Cheng and Lars Hammarström and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Infection and Immunity.

In The Last Decade

Hesham Basma

9 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hesham Basma United States 9 212 186 56 53 50 9 355
Ann‐Marie Bergholm Sweden 8 299 1.4× 232 1.2× 43 0.8× 41 0.8× 70 1.4× 16 382
Paola Cornacchione Italy 10 157 0.7× 73 0.4× 117 2.1× 72 1.4× 131 2.6× 17 386
Chunlei Wang Taiwan 11 71 0.3× 172 0.9× 13 0.2× 103 1.9× 40 0.8× 20 367
Camila Matias Peres Brazil 7 43 0.2× 101 0.5× 109 1.9× 64 1.2× 95 1.9× 7 361
Daniel S. Selinger United States 9 105 0.5× 73 0.4× 68 1.2× 53 1.0× 132 2.6× 12 374
John Weiss United States 11 57 0.3× 92 0.5× 21 0.4× 120 2.3× 44 0.9× 18 441
Julien Senécal Canada 10 32 0.2× 231 1.2× 147 2.6× 101 1.9× 140 2.8× 12 505
Mitsuo Kitahara United States 11 24 0.1× 138 0.7× 68 1.2× 40 0.8× 117 2.3× 19 350
C. Heymans Belgium 9 23 0.1× 152 0.8× 36 0.6× 63 1.2× 116 2.3× 12 349
Elisa Anastasi United Kingdom 9 74 0.3× 219 1.2× 26 0.5× 134 2.5× 20 0.4× 15 437

Countries citing papers authored by Hesham Basma

Since Specialization
Citations

This map shows the geographic impact of Hesham Basma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hesham Basma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hesham Basma more than expected).

Fields of papers citing papers by Hesham Basma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hesham Basma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hesham Basma. The network helps show where Hesham Basma may publish in the future.

Co-authorship network of co-authors of Hesham Basma

This figure shows the co-authorship network connecting the top 25 collaborators of Hesham Basma. A scholar is included among the top collaborators of Hesham Basma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hesham Basma. Hesham Basma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ikari, Jun, Amy Nelson, Shunichiro Iwasawa, et al.. (2017). Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease. PLoS ONE. 12(9). e0184039–e0184039. 18 indexed citations
2.
Michalski, Joel, Nobuhiro Kanaji, Xiangde Liu, et al.. (2012). Attenuation of Inhibitory Prostaglandin E2 Signaling in Human Lung Fibroblasts Is Mediated by Phosphodiesterase 4. American Journal of Respiratory Cell and Molecular Biology. 47(6). 729–737. 10 indexed citations
3.
Nakanishi, Masanori, Tadashi Sato, Amy Nelson, et al.. (2011). Prostaglandin E2 Stimulates the Production of Vascular Endothelial Growth Factor through the E-Prostanoid–2 Receptor in Cultured Human Lung Fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 46(2). 217–223. 22 indexed citations
4.
Basma, Hesham, et al.. (2005). BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53. Journal of Biomedical Science. 12(6). 999–1011. 17 indexed citations
5.
Beum, Paul V., Hesham Basma, Dhundy R. Bastola, & Pi-Wan Cheng. (2004). Mucin biosynthesis: upregulation of core 2 β1,6N-acetylglucosaminyltransferase by retinoic acid and Th2 cytokines in a human airway epithelial cell line. American Journal of Physiology-Lung Cellular and Molecular Physiology. 288(1). L116–L124. 24 indexed citations
6.
Norrby‐Teglund, Anna, Nahla Ihendyane, Hesham Basma, et al.. (2000). Relative Neutralizing Activity in Polyspecific IgM, IgA, and IgG Preparations against Group A Streptococcal Superantigens. Clinical Infectious Diseases. 31(5). 1175–1182. 44 indexed citations
7.
Basma, Hesham, Anna Norrby‐Teglund, Y. Guédez, et al.. (1999). Risk Factors in the Pathogenesis of Invasive Group A Streptococcal Infections: Role of Protective Humoral Immunity. Infection and Immunity. 67(4). 1871–1877. 105 indexed citations
8.
Norrby‐Teglund, Anna, Hesham Basma, Jan Andersson, et al.. (1998). Varying Titers of Neutralizing Antibodies to Streptococcal Superantigens in Different Preparations of Normal Polyspecific Immunoglobulin G: Implications for Therapeutic Efficacy. Clinical Infectious Diseases. 26(3). 631–638. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026